An experimental ‘mosaic’ vaccine against a wide variety of HIV strains is well-tolerated and generated comparable and robust immune responses in healthy adults and rhesus macaques, according to a new study published in The Lancet. The ‘mosaic’ vaccine candidate protected against infection with an HIV-like virus in rhesus macaques. Almost 37 million people worldwide are living with HIV/AIDS, with an estimated 1.8 million new cases every year....
